149 related articles for article (PubMed ID: 24693311)
1. The Fusion Protein of CTP-HBcAg18-27-Tapasin Mediates the Apoptosis of CD8(+)T Cells and CD8(+) T Cell Response in HLA-A2 Transgenic Mice.
Tang YY; Tang ZH; Zhang Y; Zhuo M; Zang GQ; Chen XH; Yu YS
Hepat Mon; 2014 Feb; 14(2):e16161. PubMed ID: 24693311
[TBL] [Abstract][Full Text] [Related]
2. Tapasin modification on the intracellular epitope HBcAg18-27 enhances HBV-specific CTL immune response and inhibits hepatitis B virus replication in vivo.
Chen X; Tang Y; Zhang Y; Zhuo M; Tang Z; Yu Y; Zang G
Lab Invest; 2014 May; 94(5):478-90. PubMed ID: 24614195
[TBL] [Abstract][Full Text] [Related]
3. [The fusion protein of cytoplasmic transduction peptide (CTP)-HBcAg18-27-Tapasin enhances specific immune response to hepatitis B virus and inhibits viral replication in transgenic mice].
Tang Y; Chen X; Zhou L; Zhuo M; Zang G; Tang Z; Yu Y
Zhonghua Gan Zang Bing Za Zhi; 2014 Jan; 22(1):24-9. PubMed ID: 24721239
[TBL] [Abstract][Full Text] [Related]
4. [Secretion of Th1-type cytokines and production of HBV-specific cytotoxic T lymphocytes in C57BL/6 mice induced by cytoplasmic transduction peptide-HBcAg18-27-Tapasin].
Tang Y; Chen X; Tang Z; Zang G; Yu Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Mar; 29(3):229-32. PubMed ID: 23643075
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Tapasin-modified CTL epitope peptide via cytoplasmic transduction peptide induces CTLs by JAK/STAT signaling pathway in vivo.
Wu S; Chen X; Tang Y; Zhang Y; Li D; Chen J; Wang J; Tang Z; Zang G; Yu Y
Acta Biochim Biophys Sin (Shanghai); 2018 Feb; 50(2):181-190. PubMed ID: 29340620
[TBL] [Abstract][Full Text] [Related]
6. The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.
Chen X; Liu H; Tang Z; Yu Y; Zang G
Acta Biochim Biophys Sin (Shanghai); 2013 Mar; 45(3):203-12. PubMed ID: 23299079
[TBL] [Abstract][Full Text] [Related]
7. [Dynamic changes and clinical significance of HBcAg18-27 specific cytotoxic T lymphocytes in acute hepatitis B patients].
Li J; Han YP; Liu B; Liu Y; Chen N; Dong L; Yan YD; Jiang LF; Huang ZH
Zhonghua Gan Zang Bing Za Zhi; 2011 Jan; 19(1):38-43. PubMed ID: 21272457
[TBL] [Abstract][Full Text] [Related]
8. [The effect of stimulation of dendritic cell on HBV-epitopic cytotoxic T-lymphocyte].
Zhang HH; He Y; Zhao H; Piao WH; Liu MC; Xi HL; Yu M; Wang GQ
Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1171-6. PubMed ID: 16029590
[TBL] [Abstract][Full Text] [Related]
9. Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice.
Nanjundappa RH; Wang R; Xie Y; Umeshappa CS; Xiang J
Vaccine; 2012 May; 30(24):3519-25. PubMed ID: 22484292
[TBL] [Abstract][Full Text] [Related]
10. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
[TBL] [Abstract][Full Text] [Related]
11. Fusion protein of tapasin and hepatitis B core antigen 18‑27 enhances T helper cell type 1/2 cytokine ratio and antiviral immunity by inhibiting suppressors of cytokine signaling family members 1/3 in hepatitis B virus transgenic mice.
Tang Y; Chen X; Zhang Y; Tang Z; Zhuo M; Li D; Wang P; Zang G; Yu Y
Mol Med Rep; 2014 Apr; 9(4):1171-8. PubMed ID: 24535102
[TBL] [Abstract][Full Text] [Related]
12. An Engineered DC-Targeting Lentivector Induces Robust T Cell Responses and Inhibits HBV Replication in HBV Transgenic Mice via Upregulating T Cell Autophagy.
Ma S; Chen X; Tan Q; Dai S; Li D; Wu S; Yu Y; Zang G; Tang Z
Cell Physiol Biochem; 2018; 48(3):1041-1059. PubMed ID: 30041239
[TBL] [Abstract][Full Text] [Related]
13. [PD-1 expression in HBcAg-specific CD8+ T cells of adolescents with chronic HBV infection].
Zhou JY; Zhou DF; Li JQ
Zhonghua Gan Zang Bing Za Zhi; 2013 Jan; 21(1):27-32. PubMed ID: 23663759
[TBL] [Abstract][Full Text] [Related]
14. Correlation between low tapasin expression and impaired CD8+ T‑cell function in patients with chronic hepatitis B.
Tang Y; Wang J; Zhang Y; Zhuo M; Song L; Tang Z; Zang G; Chen X; Yu Y
Mol Med Rep; 2016 Oct; 14(4):3315-22. PubMed ID: 27510296
[TBL] [Abstract][Full Text] [Related]
15. A chimeric HLA-A2:β2M:Ig fusion protein for the study of virus-specific CD8
Ribeiro ÁL; Araújo FP; Martins JP; Lourenço AA; Huang J; Pereira FV; Andrade LAF; Paim AAO; da Fonseca FG; Barbosa-Stancioli EF; Martins-Filho OA; Peruhype-Magalhães V; Tsuji M; Coelho-Dos-Reis JG
J Immunol Methods; 2021 May; 492():112997. PubMed ID: 33600818
[TBL] [Abstract][Full Text] [Related]
16. Ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances HBV-specific humoral and CTL immune responses in vivo.
Song L; Zhuo M; Tang Y; Chen X; Tang Z; Zang G
Int Immunopharmacol; 2014 Nov; 23(1):1-7. PubMed ID: 25135878
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus Vector Harboring the HBcAg and Tripeptidyl Peptidase II Genes Induces Potent Cellular Immune Responses In Vivo.
Tan Q; Ma S; Hu J; Chen X; Yu Y; Tang Z; Zang G
Cell Physiol Biochem; 2017; 41(2):423-438. PubMed ID: 28214886
[TBL] [Abstract][Full Text] [Related]
18. The delivery of HBcAg via Tat-PTD enhances specific immune response and inhibits Hepatitis B virus replication in transgenic mice.
Chen X; Lai J; Pan Q; Tang Z; Yu Y; Zang G
Vaccine; 2010 May; 28(23):3913-9. PubMed ID: 20394723
[TBL] [Abstract][Full Text] [Related]
19. The downregulation of Tapasin in dendritic cell regulates CD8
Chen J; Shen L; Guo Q; Ma S; Zhang Y; Chen J; Qu L; Ng SS; Chen X
J Med Virol; 2024 Mar; 96(3):e29546. PubMed ID: 38516804
[TBL] [Abstract][Full Text] [Related]
20. Human MHC class I molecule, HLA-A2.1, mediates activation of CD8
Mani R; Abdelaziz MH; Michelon A; Suzuki Y
Front Immunol; 2022; 13():1005059. PubMed ID: 36311799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
